Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin

Joseph P. Kennedy, Gyorgyi Fenyvesi, Richard P. Levy, Ken S. Rosenthal

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


This paper summarizes the peculiarities of HPMA copolymer-bound doxorubicin as an anticancer drug. It was found that polymer-bound doxorubicin demonstrated higher anticancer activity compared with free doxorubicin. This phenomenon was explained by the following mechanisms of its anticancer action: preferential accumulation in tumors, internalization in membrane-limited organelles, ability to overcome existing multidrug resistance and not to induce it de novo, high intracellular toxicity and inhibition of detoxification enzymes, cell death induction by the activation of specific signaling pathways, and triggering of caspase activation cascades.

Original languageEnglish (US)
Pages (from-to)35-47
Number of pages13
JournalMacromolecular Symposia
StatePublished - Sep 3 2001
Externally publishedYes

ASJC Scopus subject areas

  • Condensed Matter Physics
  • Organic Chemistry
  • Polymers and Plastics
  • Materials Chemistry


Dive into the research topics of 'Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin'. Together they form a unique fingerprint.

Cite this